LataMed AI Corp. (OTC: LMED), a healthcare technology company developing digital health and artificial intelligence solutions for Latin America, announced today that its Venezuelan subsidiary, LATAMEDAI VE, has entered into an agreement with the Venezuelan Institute for Scientific Research (IVIC) to develop a digital platform module. This module is intended to support access to designated laboratory and scientific services, marking a strategic expansion of the company's capabilities beyond patient-facing telemedicine.
Under the agreement, LataMed AI and IVIC will collaborate on the design, development, testing, and implementation of a digital interface. This interface will allow authorized business and institutional users to request available laboratory services, schedule appointments, monitor the status of submitted requests, access approved reports and documentation, and complete authorized payment-related processes. The proposed module aims to provide a centralized digital workflow for organizations seeking scientific and laboratory services in areas including healthcare, pharmaceuticals, food production, agriculture, and related industries. The specific services made available through the platform will be determined by IVIC and implemented in accordance with technical, operational, security, and legal requirements established by both parties.
The collaboration will begin with defining the module's functional requirements, user-access procedures, data architecture, payment workflows, document-management capabilities, and a phased testing and implementation process. The parties will also establish procedures governing the handling, transmission, storage, and authorized access to laboratory-related information and documentation. The contemplated platform functionality may include electronic service requests, appointment scheduling, request-status tracking, secure payment facilitation, and controlled access to laboratory reports or other authorized documentation. The final functionality, implementation schedule, and scope of available services remain subject to continued technical development, testing, and approval by the parties.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated, "This agreement represents an opportunity to apply our technology to an important area of scientific and enterprise service delivery. Our objective is to work with IVIC to develop a responsible digital framework that makes it easier for authorized users to request services, manage appointments, monitor processes, and access approved information through a centralized platform."
Management believes the proposed module may expand LataMed AI's capabilities beyond patient-facing telemedicine by demonstrating how its technology can support institutional and enterprise workflows involving healthcare, scientific services, laboratory coordination, and digital documentation. This initiative aligns with the company's broader strategy of developing digital infrastructure that connects patients, healthcare professionals, pharmacies, insurers, payment providers, wellness organizations, institutions, and other participants in the healthcare and scientific-services ecosystem.
If successfully implemented, management believes the module could provide a framework adaptable for other institutional and enterprise service environments in Venezuela and elsewhere in Latin America. However, any future expansion would remain subject to separate agreements, technical readiness, applicable regulatory requirements, and the needs of participating institutions. The agreement establishes the framework for development and evaluation but does not guarantee a specific implementation date, level of user adoption, service volume, revenue, profitability, or expansion to additional institutions. The company will provide further updates regarding development, testing, and implementation as appropriate.
For additional information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
